Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Shanghai Yunyi Health Technology
Welcome,
Profile
Billing
Logout
Products
Diseases
Products
Trials
News
|||
|||||||
PE0116
/
HyaMab
Enrollment open, Trial initiation date, Metastases:
PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor
(clinicaltrials.gov) - Dec 14, 2023
P1/2
, N=120, Recruiting,
Sponsor: Shanghai HyaMab Biotech Co.,Ltd.
Not yet recruiting --> Recruiting | Initiation date: May 2023 --> Sep 2023
||||
||||||
PE0105
/
Shanghai Yunyi Health Technology
,
PE0116
/
HyaMab
New P1/2 trial, Metastases:
A Phase Ib/II Clinical Trial of PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor
(clinicaltrials.gov) - Sep 7, 2023
P1/2
, N=120, Not yet recruiting,
Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.
||||
||||||
PE0116
/
HyaMab
New P1/2 trial, Metastases:
PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor
(clinicaltrials.gov) - Apr 6, 2023
P1/2
, N=120, Not yet recruiting,
Sponsor: Shanghai HyaMab Biotech Co.,Ltd.